Procter & Gamble has agreed to acquire vitamin and supplement maker Thorne HealthTech for $3.8 billion, according to regulatory filings and company announcements released in recent filings.
Transaction Details and Financial Terms
The transaction places a $3.8 billion valuation on Thorne HealthTech. Chief Executive Officer statements reported by CNBC confirmed the strategic intent behind absorbing the supplement maker into Procter & Gamble’s existing health care division, which already houses brands focused on personal care and wellness.
Strategic Impact on P&G Health Care Portfolio
According to corporate filings, the move aligns with broader shifts in consumer spending toward preventive health and personalized nutrition.
Corporate Restructuring and Operational Shifts
Alongside the announcement of the $3.8 billion brand acquisition, Procter & Gamble disclosed details regarding ongoing operational adjustments, including job cuts outlined in federal filings.
Keep reading